Nature Reviews Cancer
Springer Nature (2001-)ISSN: 1474-175X (1474-1768)
Oncology - Cancer Research - Oncology
APC Discount
We do not know if this journal supports Open Access publishing, so we also do not know about any Article Processing ChargesFor this journal no deals have been made concerning APC discounts.More information on Open Access publishing
Green Open Access
You Share, We Take Care!
Based on of the Taverne Amendment (art. 25fa Auteurswet), the publishers’ version (PDF) of short academic works can be made available via the university repository six months after the first (online) publication. General conditions for participation are mentioned here . Exact implementation may differ per institution. Please contact your university library for more details.
Open Policy Finder info
Official publisher policyOpen Policy Finder information is accurate to the best of our knowledge but should not be relied upon for legal advice. (Last modified on: {{item.system_metadata.date_modified}})
For most accurate information, visit the Journal Home Page
Open Access pathways permitted by this journal's policy are listed below by article version.
Click on a pathway for a more detailed view.
{{permission.article_version_phrases[iversion].phrase}} version
- Prerequisite: {{phrase.phrase}}.
- Prerequisite for funders: , {{name.name}}.
- No additional fee for OA publishing via this route.
- There is an additional fee for OA publishing via this route.
- There is a {{permission.embargo.amount}} {{permission.embargo.units}} embargo period for OA publishing via this route.
- There is no embargo period for OA publishing via this route.
- Copyright is owned by {{permission.copyright_owner}} when publishing via this route.
- License: {{phrase.phrase}} {{license.version}}
- Publisher deposit: {{name.name}}
- Note: {{note}}
- {{ location.phrase }} in this list: , {{repo}}.
- {{condition}}.
{{permission.article_version_phrases[iversion].phrase}} version
- Prerequisite: {{phrase.phrase}}.
- Prerequisite for funders: , {{name.name}}.
- No additional fee for OA publishing via this route.
- There is an additional fee for OA publishing via this route.
- There is a {{permission.embargo.amount}} {{permission.embargo.units}} embargo period for OA publishing via this route.
- There is no embargo period for OA publishing via this route.
- Copyright is owned by {{permission.copyright_owner}} when publishing via this route.
- License: {{phrase.phrase}} {{license.version}}
- Publisher deposit: {{name.name}}
- Note: {{note}}
- {{ location.phrase }} in this list: , {{repo}}.
- {{condition}}.
{{permission.article_version_phrases[iversion].phrase}} version
- Prerequisite: {{phrase.phrase}}.
- Prerequisite for funders: , {{name.name}}.
- No additional fee for OA publishing via this route.
- There is an additional fee for OA publishing via this route.
- There is a {{permission.embargo.amount}} {{permission.embargo.units}} embargo period for OA publishing via this route.
- There is no embargo period for OA publishing via this route.
- Copyright is owned by {{permission.copyright_owner}} when publishing via this route.
- License: {{phrase.phrase}} {{license.version}}
- Publisher deposit: {{name.name}}
- Note: {{note}}
- {{ location.phrase }} in this list: , {{repo}}.
- {{condition}}.
More information:
See Open Policy Finder record for this journal
Metrics
Scopus Journal Metrics (2024)
SJR: 24.378
SNIP: 11.131
CiteScore: 103.8
Rank within the category: Biochemistry, Genetics and Molecular Biology - Cancer Research
Quartile: Q1
CiteScore percentile: 99%
CiteScore rank: 1 out of 233
Rank within the category: Medicine - Oncology
Quartile: Q1
CiteScore percentile: 99%
CiteScore rank: 3 out of 415
Recent Articles In: {{toc.journal.substring(17,toc.journal.length)}}
{{article.title}} {{article.title}}